Abstract: A catalyst for purification of exhaust gas in which Pd-based nanoparticles and ceria nanoparticles are supported on a composite metal oxide support containing alumina, ceria, and zirconia, wherein a molar ratio (Ce/Pd) of Ce and Pd supported on the support is 1 to 8, a proximity ? between Pd and Ce is 0.15 to 0.50, wherein the proximity ? is determined, based on Pd and Ce distribution maps in an element mapping image of energy dispersive X-ray analysis, by the following formula (1): ? = ? j = 0 N - 1 ? ? i = 0 M - 1 ? ( ( I ? ( i , j ) - I ave ) ? ( T ? ( i , j ) - T ave ) ) ? j = 0 N - 1 ? ? i = 0 M - 1 ? ( I ? ( i , j ) - I ave ) 2 - ? j = 0 N - 1 ? ? i = 0 M - 1 ? ( T ? ( i , j ) - T ave ) 2 , ( 1 ) a Pd dispersity after a heat-resistance test at 1050° C. for 25 hours is 0.8% or more.

Abstract: Provided are a composition comprising a GAG derivative and a chemokine receptor activity regulator, and a pharmaceutical composition comprising said composition.

Abstract: Provided are a composition comprising a GAG derivative and a chemokine receptor activity regulator, and a pharmaceutical composition comprising said composition.

Abstract: Provided is a chondroitin sulfate derivative having a cross-linked structure through a group in a polyvalent amine. Also provided is a composition containing the chondroitin sulfate derivative. Also provided are an agent and method for the treatment of an eye disease, the agent and method having a therapeutic effect on a corneal epithelial disorder and/or dry eye.

Abstract: A compound includes a group derived from chondroitin sulfate, a group derived from a steroid, and a spacer. The group derived from the chondroitin sulfate and the group derived from the steroid are covalently bonded together via the spacer, and a spacer forming molecule of the spacer is ?-alanine or isoleucine. A covalent bond between the group derived from the steroid and the spacer is an ester bond, and a covalent bond between the group derived from the chondroitin sulfate and the spacer is an amide bond. The steroid is at least one selected from the group consisting of prednisolone, betamethasone, triamcinolone, triamcinolone acetonide, budesonide and fluticasone.

Abstract: Provided is a chondroitin sulfate derivative having a cross-linked structure through a group in a polyvalent amine. Also provided is a composition containing the chondroitin sulfate derivative. Also provided are an agent and method for the treatment of an eye disease, the agent and method having a therapeutic effect on a corneal epithelial disorder and/or dry eye.

Abstract: An electronic device includes: an operation unit including a fingerprint sensor, a longitudinal direction of the operation unit being defined as a first direction; and a processor that performs fingerprint authentication processing and processing to respond to movement of a finger of a user in the first direction on the operation unit, based on a detection result by the fingerprint sensor, in which a sensing unit of the fingerprint sensor is displaced from the center of the operation unit in the first direction.

Abstract: Provided is a chondroitin sulfate derivative having a cross-linked structure through a group in a polyvalent amine. Also provided is a composition containing the chondroitin sulfate derivative. Also provided are an agent and method for the treatment of an eye disease, the agent and method having a therapeutic effect on a corneal epithelial disorder and/or dry eye.

Abstract: Provided is a chondroitin sulfate derivative having a cross-linked structure through a group in a polyvalent amine. Also provided is a composition containing the chondroitin sulfate derivative. Also provided are an agent and method for the treatment of an eye disease, the agent and method having a therapeutic effect on a corneal epithelial disorder and/or dry eye.

Abstract: A compound includes a group derived from chondroitin sulfate, a group derived from a steroid, and a spacer. The group derived from the chondroitin sulfate and the group derived from the steroid are covalently bonded together via the spacer, and a spacer forming molecule of the spacer is ?-alanine or isoleucine. A covalent bond between the group derived from the steroid and the spacer is an ester bond, and a covalent bond between the group derived from the chondroitin sulfate and the spacer is an amide bond. The steroid is at least one selected from the group consisting of prednisolone, betamethasone, triamcinolone, triamcinolone acetonide, budesonide and fluticasone.

Abstract: Provided is a compound in which a group derived from chondroitin sulfate and a group derived from a steroid are covalently bonded together via a spacer represented by general formula (I). In the formula, m represents an integer of 0 or 1. Here, if m=0, R1 represents a group selected from the group consisting of electron-donating groups and steric hindrance groups. If m=1, R1 represents a group selected from the group consisting of a hydrogen atom, electron-donating groups and steric hindrance groups.

Abstract: An electronic device includes: an operation unit including a fingerprint sensor, a longitudinal direction of the operation unit being defined as a first direction; and a processor that performs fingerprint authentication processing and processing to respond to movement of a finger of a user in the first direction on the operation unit, based on a detection result by the fingerprint sensor, in which a sensing unit of the fingerprint sensor is displaced from the center of the operation unit in the first direction.

Abstract: Provided are a composition comprising a GAG derivative and a chemokine receptor activity regulator, and a pharmaceutical composition comprising said composition.

Abstract: Provided is a chondroitin sulfate derivative having a structure cross-linked with a group in a polyvalent amine. Also provided is a composition containing the chondroitin sulfate derivative. Also provided are an agent and method for the treatment of an eye disease, the agent and method having a therapeutic effect on a corneal epithelial disorder and/or dry eye.

Abstract: Provided is a compound in which a group derived from chondroitin sulfate and a group derived from a steroid are covalently bonded together via a spacer represented by general formula (I). In the formula, m represents an integer of 0 or 1. Here, if m=0, R1 represents a group selected from the group consisting of electron-donating groups and steric hindrance groups. If m=1, R1 represents a group selected from the group consisting of a hydrogen atom, electron-donating groups and steric hindrance groups.

Abstract: An automotive interior material comprises: a polyester needle-punched nonwoven fabric; and a polycarbonate-based polyurethane resin attached to the polyester needle-punched nonwoven fabric, wherein the polycarbonate-based polyurethane resin is obtained by reacting an organic polyisocyanate with a polyol comprising 30 to 99% by mass of a polycarbonate diol represented by the following general formula (1): wherein R1s each independently represent an alkylene group having 4 to 8 carbon atoms, and n represents an integer with which a molecular weight of the compound represented by the formula (1) is in a range from 1000 to 3500, with a mole ratio between NCO groups of the organic polyisocyanate and OH groups of the polyol (the number of moles of NCO groups/the number of moles of OH groups) being 1.5/1.0 to 1.1/1.

Abstract: An information processing apparatus includes a sensor; a touch panel; and a processor coupled to the sensor and the touch panel and is configured to control the information processing apparatus, wherein the sensor is configured to transmit an interrupt notification to the touch panel so as to wake up the touch panel when detecting an operation performed upon the sensor, and wherein the touch panel is configured to: determine whether a contact with the touch panel has been detected when being waked up, and transmit an interrupt notification to the processor so as to wake up the processor when it is determined that a contact with the touch panel has not been detected.

Abstract: An authentication apparatus includes a processor that performs a process including detecting an environmental illuminance, retrieving, from a storage configured to store a plurality of registered iris data in association with registered environmental illuminances, one of the plurality of registered iris data stored in association with a registered environmental illuminance having a minimum difference with the environmental illuminance detected by the detecting at a time of an authentication, imaging an imaging target to obtain an image data at the time of the authentication, extracting an input iris data from the image data obtained by the imaging, and matching the input iris data to the one of the plurality of registered iris data retrieved by the retrieving. A first process that includes the detecting and the retrieving, and a second process that includes the imaging, the extracting, and the matching, are executed in parallel.

Abstract: In order to control the amount of evaporation of discharged agent droplets and so that a user can inhale agent droplets having a constant diameter regardless of use environment, an inhalation apparatus includes an airflow path communicating with a suction port through which the user inhales an agent, an agent discharging portion configured to discharge an agent supplied to the airflow path, and a humidifier located outside the airflow path and configured to humidify an airflow in the airflow path generated by an inhalation of the user.

Abstract: In order to control the amount of evaporation of discharged agent droplets and so that a user can inhale agent droplets having a constant diameter regardless of use environment, an inhalation apparatus includes an airflow path communicating with a suction port through which the user inhales an agent, an agent discharging portion configured to discharge an agent supplied to the airflow path, and a humidifier located outside the airflow path and configured to humidify an airflow in the airflow path generated by an inhalation of the user.